BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Wednesday, January 14, 2026
Home » Authors » Mark McCarty

Articles by Mark McCarty

FDA reviewer takes podium as private citizen at 510(k) affair

Feb. 22, 2010
By Mark McCarty
The normal course of affairs at FDA meetings – advisory meetings and other kinds – is that government employees do not speak as private citizens and that center and division chiefs do not represent FDA at those meetings. For the second time in 16 months, this pattern was broken as Robert Smith, MD, a reviewer of radiological products at the Center for Devices and Radiological Health, took to the podium to present his views as a private citizen on the 510(k) program. (Medical Device Daily)
Read More

Predicate creep, resources driving FDA's 510(k) angst

Feb. 19, 2010
By Mark McCarty
Yesterday's meeting with managers at the Center for Devices and Radiological Health at FDA to address the much-maligned 510(k) program painted a picture that had to be discouraging to industry for a couple of reasons. One is that FDA staff indicated that the center's reviewers are swamped with the several types of 510(k) applications and the other is that the "predicate tree" is described in data files at FDA that are often either incomplete or have been truncated, leaving a dead end trail for those inside and outside the agency who are attempting to flesh out the current state of affairs for a device type. (Medical Device Daily)
Read More

Washington roundup: DoJ's task force for IP theft excludes PTO representative

Feb. 17, 2010
By Mark McCarty

Washington roundup: Ultrasound, OCT may benefit from crackdown on radiation

Feb. 11, 2010
By Mark McCarty

Washington roundup: FDA pushes others for ideas for new regulatory approach

Feb. 10, 2010
By Mark McCarty

Washington roundup: NIH urges greater push for colorectal cancer screening

Feb. 9, 2010
By Mark McCarty

Washington roundup: CDRH, device makers making no use of warning letter close-outs

Feb. 8, 2010
By Mark McCarty

Washington roundup: Steris continues selling SS1 outside U.S., refiles 510(k)

Feb. 4, 2010
By Mark McCarty

Washington roundup: Warning to ELA for ICDs may be tied to cleaning validation

Feb. 3, 2010
By Mark McCarty

Washington roundup: White House argues for FDA budget of $4B in fiscal 2011

Feb. 2, 2010
By Mark McCarty
Previous 1 2 … 490 491 492 493 494 495 496 497 498 … 577 578 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Jan 13, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for Jan. 13, 2026.
  • 3D rendering of antibody drug conjugated with cytotoxic payload

    ADCs’ breakout 2025 and their still-unfinished potential

    BioWorld
    Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
  • Lung cancer illustration

    LINC01116 has prognostic value in lung cancer, study shows

    BioWorld MedTech
    Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
  • SERPINB1 as potential biomarker for spinocerebellar ataxia type 2

    BioWorld Science
    Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • NME Digest
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing